Home Online Features Alzheimer's Drug Discovery Foundation's Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA's SpeechDx Dataset, Gold-Standard Dataset for Alzheimer's Speech Biomarkers
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers
Hand-out
Press Releases
Alzheimer's Drug Discovery Foundation  
May 1, 2025

Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers

Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing a speech-based biomarker for Alzheimer's disease.

avatar profile Olean Times Herald

Olean Times Herald

email Olean Times Herald

Local & Social